Kyverna Therapeutics Inc (KYTX) PT Lowered to $33 at JPMorgan
Tweet
Share
E-mailGet Alerts KYTX Hot Sheet
Price: $7.82 -1.01%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
JPMorgan analyst Brian Cheng lowered the price target on Kyverna Therapeutics Inc (NASDAQ: KYTX) to $33.00 (from $39.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis
- Citi Downgrades Ecopetrol SA (EC) to Neutral
- Medtronic, Inc. (MDT) PT Lowered to $101 at Needham
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
